Carnosine: Dosing Protocols
Dosing guidelines, reconstitution, and administration information
๐TL;DR
- โข3 dosing protocols documented
- โขReconstitution instructions included
- โขStorage: Store carnosine supplements in a cool, dry place away from direct sunlight and moisture. Sealed containers at room temperature are adequate for capsule and tablet formulations. N-acetylcarnosine eye drops should be stored according to manufacturer instructions, typically refrigerated after opening.
Protocol Quick-Reference
Anti-aging and glycemic control support
Dosing
Amount
1-2 g/day
Frequency
Once to twice daily
Duration
12-14 weeks
Administration
Route
OralTiming
Take as oral capsules (typically two 500 mg capsules daily). No specific timing requirements; most studies used dosing with meals.
Cycle
Duration
12-14 weeks
Repeatable
Yes
โ๏ธ Suggested Bloodwork (4 tests)
Fasting glucose
When: Baseline
Why: Baseline glycemic status
HbA1c
When: Baseline
Why: Baseline long-term glucose control
Fasting glucose and HbA1c
When: 12 weeks
Why: Assess glycemic response to supplementation
CMP (Comprehensive Metabolic Panel)
When: 12 weeks
Why: Monitor liver and kidney function
๐ก Key Considerations
- โDietary supplement, not FDA-approved as a drug: sold under DSHEA
- โHuman serum carnosinase rapidly degrades circulating carnosine, potentially limiting bioavailability
- โDoses above 2 g/day are generally well tolerated, but single doses of 15 g showed unacceptable adverse events
Unlock dosing protocols
Free access to research-backed dosing information for all peptides.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
| Purpose | Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Glycemic Control (Type 2 Diabetes) | 1 g/day (two 500 mg capsules) of L-carnosine for 12 weeks in the Houjeghani et al. RCT. Significant reductions in fasting glucose, HbA1c, triglycerides, and AGE markers versus placebo. | Daily oral dosing | 12 weeks | Double-blind, placebo-controlled RCT in 54 patients with type 2 diabetes. Higher dose of 2 g/day used in the de Courten et al. 14-week trial with similar glucose-lowering effects. |
| Cognitive Function (Elderly Populations) | 1 g/day of carnosine or carnosine/anserine mixture for 12 weeks in multiple RCTs. Meta-analysis showed improvement in global cognitive function scores. | Daily oral dosing | 12 weeks | Based on systematic review and meta-analysis by Caruso et al. (2021). Effective in both healthy elderly subjects and those with mild cognitive impairment. No effects on depressive symptoms at this dose. |
| Glycemic Control (Prediabetes) | 2 g/day of L-carnosine for 14 weeks in the de Courten et al. RCT. Significant reduction in glucose AUC during OGTT, particularly at 90 and 120 minute timepoints. | Daily oral dosing | 14 weeks | RCT in 43 adults with prediabetes or early type 2 diabetes. Effects attributed to changes in hepatic glucose output rather than increased insulin secretion. |
Unlock full dosage protocols
Free access to complete dosing tables and protocol details.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
๐Reconstitution Instructions
Carnosine is available as an oral dietary supplement and does not require reconstitution. Capsules and tablets are the most common formulations. N-acetylcarnosine is available as ophthalmic eye drops (typically 1% solution). No injectable formulations are commercially available for supplementation.
๐งStorage Requirements
Store carnosine supplements in a cool, dry place away from direct sunlight and moisture. Sealed containers at room temperature are adequate for capsule and tablet formulations. N-acetylcarnosine eye drops should be stored according to manufacturer instructions, typically refrigerated after opening.
Community Dosing Protocols
Compare these clinical doses with what 100+ community members report using.
Based on 100+ community reports
View community protocolsResearch Tools
Before You Begin
Review safety warnings and contraindications before starting any protocol.
Dosing Overview#
Carnosine is an oral dietary supplement with clinical trial evidence at doses of 1-2 g per day. Unlike most peptides on this site, carnosine does not require injection or reconstitution. It is available over the counter as capsules, tablets, and powder formulations.
Clinical Trial Dosing#
Type 2 Diabetes and Glycemic Control#
Two key randomized controlled trials provide dosing guidance:
Houjeghani et al. (2018) - 1 g/day for 12 weeks:
- 54 patients with type 2 diabetes
- Two 500 mg L-carnosine capsules daily
- Significant reductions in fasting glucose (13.1 mg/dL), HbA1c, triglycerides, and carboxymethyl lysine (AGE marker)
- Well tolerated with no reported supplement-related adverse events
de Courten et al. (2024) - 2 g/day for 14 weeks:
- 43 adults with prediabetes or type 2 diabetes
- Significant reduction in glucose at 90 and 120 minutes during OGTT
- Reduction in total glucose area under the curve
- No adverse events during the intervention period
Cognitive Function#
Based on the systematic review and meta-analysis by Caruso et al. (2021):
- Dose: 1 g/day of carnosine or carnosine/anserine mixture
- Duration: 12 weeks
- Population: Elderly subjects and patients with mild cognitive impairment
- Outcome: Improved global cognitive function scores
- Note: Some studies used anserine (a related histidine dipeptide) combined with carnosine
Exercise Performance (via Beta-Alanine)#
For the specific goal of increasing muscle carnosine for exercise buffering:
- Beta-alanine dose: 3.2-6.4 g/day (in divided doses of less than 800 mg to avoid paresthesia)
- Duration: 4-12 weeks to significantly increase muscle carnosine content
- Outcome: Meta-analysis of 40 studies showed significant improvement in exercise capacity for activities lasting 0.5-10 minutes
Direct oral carnosine supplementation is less efficient for raising muscle carnosine levels due to rapid hydrolysis by serum carnosinase.
Dose Safety Range#
Based on a safety and tolerability study in healthy volunteers:
| Dose | Tolerability |
|---|---|
| Up to 2 g/day | Well tolerated, no significant adverse events in multiple RCTs |
| 5 g twice daily | Well tolerated in longer-term dosing |
| 10 g single dose | Safe but approaching upper limit |
| 15 g single dose | Unacceptably high adverse event rate (77%), including headache, nausea, paresthesia |
Administration Notes#
- Timing: No specific timing requirements established in clinical trials. Most studies used morning and/or evening dosing with meals.
- Form: Capsules, tablets, and bulk powder are all commercially available. No evidence suggests differential efficacy between forms.
- Combination: Carnosine has been studied alone and in combination with anserine (typically in a ratio from Asian dietary supplements). Both approaches showed benefits in cognitive studies.
- N-acetylcarnosine eye drops: Typically 1% NAC solution, applied topically to the eye. This is a separate formulation from oral supplements.
Bioavailability Considerations#
A critical consideration for carnosine dosing is the high activity of human serum carnosinase (CN1), which rapidly hydrolyzes circulating carnosine. The clinical benefits observed in trials at 1-2 g/day suggest that sufficient carnosine or its constituent amino acids reach target tissues despite this enzymatic barrier. The mechanisms likely involve:
- Rapid intestinal absorption of intact carnosine via PepT1 transporters
- Some tissue uptake of intact carnosine before complete hydrolysis
- Cellular resynthesis of carnosine from absorbed beta-alanine and histidine
- Direct anti-glycation and antioxidant activity in the gastrointestinal tract
Tools & Resources#
Building a multi-peptide protocol? -- Try the Protocol Schedule Builder to plan your research timeline with Carnosine alongside other peptides.
Check stack compatibility -- Verify Carnosine interactions with your other peptides using the Stack Compatibility Checker.
Explore the evidence base -- Use the Evidence Explorer to filter and sort clinical studies on Carnosine by study phase, outcome, and quality.
Related Dosing Guides#
- GHK-Cu Dosing Protocols -- Another endogenous anti-aging peptide, primarily topical
- Epitalon Dosing Protocols -- Telomere-focused anti-aging peptide
- Glutathione Dosing Protocols -- Antioxidant peptide often stacked with carnosine
- MOTS-c Dosing Protocols -- Mitochondrial-derived peptide with metabolic benefits
Compare Carnosine#
- Carnosine vs Glutathione -- Antioxidant peptide head-to-head
- Carnosine vs Epitalon -- Anti-aging peptide comparison
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Protocol updates
Get notified when we update dosing protocols or publish related comparisons.
Frequently Asked Questions About Carnosine
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.